Journal article icon

Journal article

A new polygenic score for refractive error improves detection of children at risk of high myopia but not the prediction of those at risk of myopic macular degeneration

Abstract:
Background
High myopia (HM), defined as a spherical equivalent refractive error (SER) ≤ -6.00 diopters (D), is a leading cause of sight impairment, through myopic macular degeneration (MMD). We aimed to derive an improved polygenic score (PGS) for predicting children at risk of HM and to test if a PGS is predictive of MMD after accounting for SER.
Methods
The PGS was derived from genome-wide association studies in participants of UK Biobank, CREAM Consortium, and Genetic Epidemiology Research on Adult Health and Aging. MMD severity was quantified by a deep learning algorithm. Prediction of HM was quantified as the area under the receiver operating curve (AUROC). Prediction of severe MMD was assessed by logistic regression.
Findings
In independent samples of European, African, South Asian and East Asian ancestry, the PGS explained 19% (95% confidence interval 17-21%), 2% (1-3%), 8% (7-10%) and 6% (3-9%) of the variation in SER, respectively. The AUROC for HM in these samples was 0.78 (0.75-0.81), 0.58 (0.53-0.64), 0.71 (0.69-0.74) and 0.67 (0.62-0.72), respectively. The PGS was not associated with the risk of MMD after accounting for SER: OR = 1.07 (0.92-1.24).
Interpretation
Performance of the PGS approached the level required for clinical utility in Europeans but not in other ancestries. A PGS for refractive error was not predictive of MMD risk once SER was accounted for.
Funding
Supported by the Welsh Government and Fight for Sight (24WG201).
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.ebiom.2023.104551

Authors

More by this author
Role:
Author
ORCID:
0000-0003-2689-5896

Contributors

Role:
Contributor
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Contributor
Institution:
University of Oxford
Division:
MSD
Department:
Psychiatry
Role:
Contributor


More from this funder
Funder identifier:
https://ror.org/000wh6t45
Grant:
24WG201
Programme:
co-supported with Fight for Sight
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MC_PC_19009
MR/T033371/1
MC_PC_15018
More from this funder
Funder identifier:
https://ror.org/0472cxd90
Grant:
648268


Publisher:
Elsevier
Journal:
EBioMedicine More from this journal
Volume:
91
Article number:
104551
Place of publication:
Netherlands
Publication date:
2023-04-11
Acceptance date:
2023-03-17
DOI:
EISSN:
2352-3964
Pmid:
37055258


Language:
English
Keywords:
Pubs id:
1340439
Local pid:
pubs:1340439
Deposit date:
2025-06-25
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP